We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-17.12%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$10.3B
AUM Growth
-$5.42B
Cap. Flow
-$3B
Cap. Flow %
-29.02%
Top 10 Hldgs %
54.96%
Holding
62
New
4
Increased
17
Reduced
26
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 53.29%
2 Materials 13%
3 Technology 8.91%
4 Industrials 8.58%
5 Communication Services 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHTR icon
51
Charter Communications
CHTR
$18.8B
-625,629
Closed -$204M
DLTR icon
52
Dollar Tree
DLTR
$24.6B
-1,196,359
Closed -$97.6M
FBIN icon
53
Fortune Brands Innovations
FBIN
$5.97B
-2,849,926
Closed -$128M
GEN icon
54
Gen Digital
GEN
$17.4B
-6,284,724
Closed -$134M
LH icon
55
Labcorp
LH
$26.1B
-90,092
Closed -$13.4M
MHK icon
56
Mohawk Industries
MHK
$9.26B
-305,126
Closed -$53.5M
NWL icon
57
Newell Brands
NWL
$2.62B
-19,392,348
Closed -$394M
MIK
58
DELISTED
Michaels Stores, Inc
MIK
-3,343,498
Closed -$54.3M
WP
59
DELISTED
Worldpay, Inc.
WP
-924,527
Closed -$93.6M
ESRX
60
DELISTED
Express Scripts Holding Company
ESRX
-8,603,438
Closed -$817M
AET
61
DELISTED
Aetna Inc
AET
-3,606,426
Closed -$732M
C.WS.A
62
DELISTED
Citigroup Inc
C.WS.A
-8,031,020
Closed -$12K

Similar funds

Glenview Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Glenview Capital Management held 62 positions worth $10.3B, down 34% from $15.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Glenview Capital Management withdrew a net $3B in Q4 2018, closing 12 positions and reducing 26 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $817M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 46% a quarter earlier, followed by Materials and Technology.

Against the trend, Glenview Capital Management opened a new position in Baxter International worth $57.7M.

  • Glenview Capital Management's largest Q4 2018 buy was Baxter International: 877,001 shares worth $57.7M.
  • Glenview Capital Management added most to Cigna in Q4 2018, an estimated $363M increase.
  • Glenview Capital Management's biggest Q4 2018 reduction was Thermo Fisher Scientific, cutting an estimated $242M.
  • Glenview Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $817M.
  • Glenview Capital Management's ten largest holdings make up 55% of its $10.3B portfolio in Q4 2018.
  • Glenview Capital Management opened 4 new positions and closed 12 in Q4 2018.
  • Glenview Capital Management's portfolio value fell 34% quarter-over-quarter to $10.3B.

Based on Glenview Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.